Thrombophlebitis

20,402views

Thrombophlebitis

hemato

hemato

Sideroblastic anemia
Microcytic anemia: Pathology review
Aplastic anemia
Macrocytic anemia: Pathology review
Anemia: Clinical
Megaloblastic anemia
Extrinsic hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Beta-thalassemia
Alpha-thalassemia
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Coagulation disorders: Pathology review
Hemophilia
Thrombophlebitis
Disseminated intravascular coagulation
Acute leukemia
Leukemias: Pathology review
Leukemia: Clinical
Chronic leukemia
Post-transplant lymphoproliferative disorders (NORD)
Myelodysplastic syndromes
Langerhans cell histiocytosis
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Plasma cell disorders: Pathology review
Plasma cell disorders: Clinical
Waldenstrom macroglobulinemia
Lymphomas: Pathology review
Non-Hodgkin lymphoma
Hodgkin lymphoma
Anti-tumor antibiotics
Blood groups and transfusions
Blood products and transfusion: Clinical
Transplant rejection
Non-corticosteroid immunosuppressants and immunotherapies
Graft-versus-host disease
Ruptured spleen
Hemochromatosis
Iron deficiency anemia
Vitamin B12 deficiency
Folate (Vitamin B9) deficiency
Sickle cell disease: Clinical
Pyruvate kinase deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Pyruvate dehydrogenase deficiency
Paroxysmal nocturnal hemoglobinuria
Hereditary spherocytosis
Bleeding disorders: Clinical
Vitamin K deficiency
Protein C deficiency
Protein S deficiency
Lymphoma: Clinical
Essential thrombocythemia (NORD)
Myeloproliferative neoplasms: Clinical
Myeloproliferative disorders: Pathology review
Introduction to the immune system
Immune thrombocytopenia
Polycythemia vera (NORD)
Acute intermittent porphyria

Flashcards

Thrombophlebitis

0 of 8 complete

Transcript

Watch video only

Thrombophlebitis can be broken down into “thrombo” or thrombus which refers to a blood clot, “phleb” which refers to a vein, and “itis” which refers to inflammation. So thrombophlebitis is a blood clot that gets lodged in a vein and causes inflammation.

Normally, the process starts with damage to the endothelium, or inner lining of the blood vessel walls, after which there’s an immediate vasoconstriction or narrowing of the blood vessel which limits the amount of blood flow. After that, some platelets adhere to the damaged vessel wall, and become activated by collagen and tissue factor, which are proteins that are normally kept separated from the blood by an intact endothelium. These platelets then recruit additional platelets to form a platelet plug. The formation of the platelet plug is called primary hemostasis.

After that, the coagulation cascade is activated. First off in the blood there’s a set of clotting factors, most of which are proteins synthesized by the liver, and usually these are inactive and just floating around in the blood. The coagulation cascade starts when one of these proteins gets proteolytically cleaved. This active protein then proteolytically cleaves and activates the next clotting factor, and so on. The final step is activation of the protein fibrinogen to fibrin, which deposits and polymerizes to form a mesh around the platelets. So these steps leading up to fibrin reinforcement of the platelet plug make up the process called secondary hemostasis and results in a hard clot at the site of the injury.

This cascade has a huge degree of amplification and takes only a few minutes from injury to clot formation. So the activation of the cascade is carefully controlled by anticoagulation proteins that target and inactivate key clotting factors. For example, antithrombin inactivates Factors IXa, Xa, XIa, XIIa, VIIa and thrombin while protein C inactivates Factors Va and VIIIa.

As the clot grows in size, it limits the amount of blood able to pass by, and pressure in the vein increases. Usually the clot might start naturally breaking down, for example, enzymes like plasmin break down fibrin into fragments called D-dimers.

There are three main factors that lead to thrombosis, which are referred to as Virchow’s triad. The first factor is slowed blood flow, also called stasis, in the veins. Typically, blood continuously flows smoothly through the blood vessel, but if the blood flow becomes turbulent, the linear flow is disrupted and slow or static pockets of blood are formed. Stasis can also happen during long periods of inactivity of the skeletal muscle pump like bed rest or long flights and car rides, or even during pregnancy when a growing baby compresses nearby veins.

During stasis, platelets and other clotting factors contact the endothelium, and prolonged interaction leads to clotting factor adhesion, and, ultimately, activation of the clotting cascade.

The second factor is a state of hypercoagulation, where altered amounts of clotting factors increase primary or secondary hemostasis. This can happen for genetic or acquired reasons like surgery or taking certain medications like birth control pills. During surgery, physical damage to the vessels activates the clotting cascade. And birth control pills tip the balance towards clotting because they increase the levels of clotting factors and decrease the levels of some anti-coagulation factors like protein C and antithrombin.

A third factor is damage to the endothelial cell lining of a blood vessel which exposes tissue factor and collagen. Damage can be caused by infections, chronic inflammation or toxins like those found in tobacco cigarettes.

Key Takeaways

Thrombophlebitis is a blood clot that gets lodged in a vein and causes inflammation. All factors that lead to abnormal clot formation are grouped into three factors, known as Virchow's triad. They include venous stasis; a state of hypercoagulation; and damage to the endothelial cell lining. Venous stasis is said when blood doesn't flow appropriately in the veins, which can occur in situations of prolonged periods of inactivity. Endothelial injury can occur when there is an injury or trauma to a blood vessel; and finally, hypercoagulable states can be seen in certain conditions like cancer, pregnancy, and certain medications such as hormonal birth control or chemotherapy.

Thrombophlebitis can cause pain, swelling, and redness in the affected area, and may be accompanied by a fever. In some cases, a clot can break loose from the vein and travel to the lungs, causing a pulmonary embolism, which can be life-threatening. The treatment of thrombophlebitis involves thrombolytics to help break down the clot, or a thrombectomy, which is an intervention that aims to surgically remove the clot. Long-term treatment to prevent future thrombi from forming can include anticoagulant medications like warfarin or heparin.